Calcium Antagonists

1. Structure-Function Studies of the Voltage-Dependent Calcium Channels.- 2. Regulation of Calcium Channels by Protein Phosphorylation.- 3. Interactions of Lacidipine and Other Calcium Channel Drugs with Biological Membranes: A Structural Model for Receptor/Drug Binding Utilizing the Membrane Bilayer.- 4. Regulation of Calcium Channels in Vascular Smooth Muscle.- 5. Calcium and the Production of Endothelium-Derived Vasoactive Factors.- 6. Postnatal Development of Calcium Channels in Cardiac Muscle.- 7. The Hemodynamic Effects of Calcium Antagonists under Pathological Conditions.- 8. Calcium, Ischemia, and the Calcium Antagonists.- 9. Multiple Organ Protection through Endothelial Cell Stabilization: A Mechanism of Action of Calcium Antagonists?.- 10. New Insight into the Vascular Properties of Lacidipine.- 11. Effect of Felodipine on Left Ventricular Performance in Conscious Dogs: Assessment by Left Ventricular Pressure-Volume Analysis.- 12. Lacidipine in the Treatment of Hypertension: Clinical Data.- 13. Insights in the Cardioprotective Mechanism of the New Drug R56865.- 14. Do the Differences between Calcium Antagonists Matter when Treating Hypertension?.- 15. Effects of Lacidipine on Ischemic and Reperfused Myocardium.- 16. Atherogenic Activity Caused by Excess Membrane Cholesterol in Arterial Smooth Muscle: Role of Calcium Channels.- 17. Understanding the Initiating Factors in Atherosclerosis: Implications for Intervention.- 18. Calcium Antagonists and Lipid-Lowering Agents in the Protection of the Arterial Wall.- 19. Calcium Channel Blockers as Agents for the Treatment of Atherosclerosis.- 20. Anti-Arteriosclerotic Effects of Calcium Antagonists: Do Calcium Antagonists Inhibit Cholesterol Accumulation in Coronary Arteries of Cholesterol-Fed Rabbits?.- 21. Cholesterol Enrichment during Dietary Atherosclerosis Alters Smooth Muscle Plasma Membrane Width and Structure: Evidence for Reversal by the 1,4-Dihydropyridine Amlodipine.- 22. Lacidipine and Atherosclerosis.- 23. Potentiation of the Antiplatelet Effect of Aspirin by the Calcium Channel Antagonist Amlodipine.- 24. The Effects of Lacidipine on Insulin Sensitivity.- 25. Calcium Antagonists, Hypertension, and Atherosclerosis.- 26. Expression, Localization, and Function of Calcium Channels in NGF-Treated PC12 Cells.- 27. Receptor-Mediated Inhibition of Calcium Currents and Synaptic Transmission in Cultured Hippocampal Pyramidal Neurons.- 28. Calcium Stores and Calcium Channels of Cerebellum Purkinje Cells.- 29. Calcium Channel Signaling in Astrocytes.- 30. Studies on Synaptosomes: New Insights on Calcium Antagonists.- 31. The Regulation of Neuronal Calcium Channels.- 32. Effect of Aging on Brain Voltage-Dependent Calcium Channels.- 33. Calcium Overload Blockade in Neurons and Cardiomyocytes.- 34. Effect of Nicardipine on Antioxidant Enzymatic Activities and LTC4 Release in Experimental SAH.- 35. Treatment of Acute Ischemic Stroke with Calcium Antagonists.- 36. Pharmacological Approach to Acute Ischemic Stroke.- 37. Calcium Antagonist and Subarachnoid Hemorrhage.- 38. Pharmacological Basis for Use of Calcium Antagonists in Dementia.- 39. Calcium Channels in Intestinal Smooth Muscle.- 40. Pharmacological Aspects of Calcium Channels in Nonvascular Smooth Muscle.- 41. Pharmacology of Calcium Antagonists Active on Gastrointestinal Calcium Channels.- 42. Role of Calcium Channels in Pharmacological Modulation of Gastrointestinal Motility.- 43. A New Class of Calcium Antagonist Selective for the GI Tract.- 44. Therapeutic Application of Calcium Antagonists in Gastroenterology.- 45. CalciumAntagonists and the Kidney: Implications for Renal Protection.- 46. Calcium Antagonists Improve the Outcome after Renal Transplantation.- 47. Reversal of P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells by Calcium Channel Antagonists.- 48. Reversal of Multiple Drug Resistance (MDR) in Malaria by Reverse Isomers of Calcium Channel Blockers and its Possible Application to Cancer and MDR Parasitic Diseases.